Medigate, a NYC-based medical device security and asset management platform, completed a $15M Series A financing.
The round was led by new investor U.S. Venture Partners (USVP) with participation by current investors YL Ventures and Blumberg Capital. In conjunction with the funding, Jacques Benkoski, partner at USVP, will join the Medigate board of directors.
The company plans to use the funds to accelerate growth and triple headcount across R&D, sales, marketing and customer success over the next 18 months.
Led by Jonathan Langer, CEO, Medigate provides a medical device security and asset management platform that identifies, fingerprints and tags each individual medical device beyond the IP address with tags based on its type, vendor and model.
The system allows hospital networks to operate all medical devices on their network, enabling deployment of existing and new devices to patients while ensuring privacy and safety.
FinSMEs
30/01/2019